Dr. Mirfakhraee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-2800Fax+1 214-645-2808
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013
- University of ColoradoResidency, Internal Medicine, 2006 - 2009
- LSU School of Medicine in ShreveportClass of 2006
Certifications & Licensure
- TX State Medical License 2009 - 2025
- CO State Medical License 2006 - 2009
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.Gregory A Ratti, Hannah Smith, Sasan Mirfakhraee, Joan Reisch, Leah Cohen
Journal of Cystic Fibrosis. 2024-10-16 - Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases.Oksana Hamidi, Mihailo Miljanic, Gayane Tumyan, Alana Christie, Sasan Mirfakhraee
Cancers. 2024-09-12 - Glucagon-like-peptide-1 agonist therapy in adults with cystic fibrosis.Sanghoon Park, Raksha Jain, Sasan Mirfakhraee
Journal of Cystic Fibrosis. 2024-08-29
Press Mentions
- Clinical Experience with Intravenous Zoledronic Acid in the Treatment of Male Osteoporosis: Evidence and OpinionsAugust 1st, 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: